Evaluation of Persistence of Resistant Variants with Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated with Telaprevir

• Xiomara V. Thomas ,

  Contributed equally to this work with: Xiomara V. Thomas, Joep de Bruijne

  * E-mail: x.v.thomas@amc.uva.nl

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands

  ⨯
• Joep de Bruijne ,

  Contributed equally to this work with: Xiomara V. Thomas, Joep de Bruijne

  Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

  ⨯
• James C. Sullivan,

  Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Tara L. Kieffer,

  Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America

  ⨯
• Cynthia K. Y. Ho,

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands

  ⨯
• Sjoerd P. Rebers,

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands

  ⨯
• Michel de Vries,

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Human Retro Virology, Amsterdam, The Netherlands

  ⨯
• Hendrik W. Reesink,

  Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

  ⨯
• Christine J. Weegink,

  Affiliation Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

  ⨯
• Richard Molenkamp,

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands

  ⨯
• Janke Schinkel

  Affiliation Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands

  ⨯